Peanut allergy: update concepts



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Allergy to peanuts is an actual problem of practical health care associated with a significant prevalence and severity of peanut-allergic reactions, which can include anaphylaxis. The characteristic of peanut allergen components is presented in the review. Modern approaches to the diagnosis of allergy to peanuts reflected in the article. The article presents research findings on development and natural history of allergy to peanuts, clinical mmanifestations, also considered the priority therapeutic approaches.

Full Text

Restricted Access

About the authors

L M Ogorodova

Siberian State Medical University

Tomsk, Russia

O S Fedorova

Siberian State Medical University

Email: osf77@list.ru
Tomsk, Russia

M M Fedotova

Siberian State Medical University

Tomsk, Russia

T A Evdokimova

Siberian State Medical University

Tomsk, Russia

References

  1. Finkelman F.D. Peanut allergy and anaphylaxis. C. Opin. Im. 2010, v. 22, p. 783-788.
  2. Федорова О.С., Огородова Л.М., Солодовникова О.В., Гонсорунова Д.С. Пищевая аллергия у детей: аспекты эпидемиологии и естественного течения. Педиатрия. 2009, т. 87, № 2, с. 120-125.
  3. Балаболкин И.И., Соснина О.Б. Пищевая аллергия у детей и подростков. Рос. Аллергол. Журн. 2006, № 3, с. 44-52.
  4. De Silva I.L., Mehr S.S., Tey D., Tang M.L. Pediatric anaphylaxis: a 5 year retrospective review. Allergy. 2008, v. 63 (8), p. 1071-1076.
  5. Boulay A., Houghton J., Gancheva V. et al. A EuroPrevall review of factors affecting incidence of peanut allergy: priorities for research and policy. Allergy. 2008, v. 63 (7), p. 797-809.
  6. Patel D.A., Holdford D.A., Edwards E., Carroll N.V. Estimating the economic burden of food-induced allergic reactions and anaphylaxis in the United States. J. Allergy Clin. Immunol. 2011, v. 128 (1), p. 110-115.
  7. Sicherer S.H., Munoz-Furlong A., Godbold J.H., Sampson H.A. US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J. Allergy Clin. Immunol. 2010, v. 125, p. 1322-1326.
  8. Grundy J., Matthews S., Bateman B. Rising prevalence of allergy to peanut in children: data from 2 sequential cohorts. J. Allergy Clin. Immunol. 2002, v. 110, p. 784-789.
  9. Kagan R.S., Joseph L., Dufresne C. Prevalence of peanut allergy in primary-school children in Montreal, Canada. J. Allergy Clin. Immunol. 2003, v. 112, p. 1223-1228.
  10. Mullins R.J., Dear K.B., Tang M.L. Characteristics of childhood peanut allergy in the Australian Capital Territory. J. Allergy Clin. Immunol. 2009, v. 123 (3), p. 689-693.
  11. Morisset M., Moneret-Vautrin D.A., Kanny G. Prevalence of peanut sensitization in a population of 4,737 subjects: an Allergo-Vigilance Network enquiry carried out in 2002. Allerg. Immunol. 2005, v. 37, p. 54-57.
  12. Osterballe M., Hansen T.K., Mortz C.G. et al. The prevalence of food hypersensitivity in an unselected population of children and adults. Pediatr. Allergy Immunol. 2005, v. 16, p. 567-573.
  13. Du Toit G., Katz Y., Sasieni P. et al. Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J. Allergy Clin. Immunol. 2008, v. 122, p. 984-991.
  14. Santadusit S., Atthapaisalsarude S., Vichyanond P. Prevalence of adverse food reactions and food allergy among Thai children. J. Med. Assoc. Thai. 2005, v. 88 (8), p. 27-32.
  15. Mondoulet L., Paty E., Drumare M.F. et al. Influence of thermal processing on the allergenicity of peanut proteins. J. Agric. Food Chem. 2005, v. 53 (11), p. 4547-4553.
  16. De Jong E.C., Van Zijverden M., Spanhaak S. et al. Identification and partial characterization of multiple major allergens in peanut proteins. Clin. Exp. Allergy 1998, v. 28 (6), p. 743-751.
  17. De Leon M.P., Rolland J.M., O’Hehir R.E. The peanut allergy epidemic: allergen molecular characterization and prospects for specific therapy. Expert Rev. Mol. Med. 2007, v. 9 (1), p. 1-18.
  18. Koppelman S.J., Bruijnzeel-Koomen C.A., Hessing M., de Jongh H.H. Heat-induced conformational changes ofAra h 1, a major peanut allergen, do not affect its allergenic properties. J. Biol. Chem. 1999, v. 274 (8), p. 4770-4777.
  19. Vereda A., van Hage M., Ahlstedt S. et al. Peanut allergy: clinical and immunologic differences among patients from 3 different geographic regions. J. Allergy Clin. Immunol. 2011, v. 127, p. 603-607.
  20. Barre A., Borges J.P., Rouge P. Molecular modelling of the major peanut allergen Ara h 1 and other homotrimeric allergens of the cupin superfamily: a structural basis for their IgE-binding cross-reactivity. Biochimie. 2005, v. 87 (6), p. 499-506.
  21. Lehmann K., Schweimer K., Reese G. et al. Structure and stability of 2S albumin-type peanut allergens: implications for the severity of peanut allergic reactions. Biochem. J. 2006, v. 395 (3), p. 463-472.
  22. De Leon M.P., Drew A.C., Glaspole I.N. et al. IgE cross-reactivity between the major peanut allergen Ara h 2 and tree nut allergens. Mol. Immunol. 2007, v. 44 (4), p. 463-471.
  23. Koppelman S.J., Vlooswijk R.A., Knippels L.M. et al. Quantification of major peanut allergens Ara h 1 and Ara h 2 in the peanut varieties Runner, Spanish, Virginia, and Valencia, bred in different parts of the world. Allergy. 2001, v. 56 (2), p. 132-137.
  24. Barre A., Jacquet G., Sordet C. et al. Homology modelling and conformational analysis of IgE-binding epitopes of Ara h 3 and other legumin allergens with a cupin fold from tree nuts. Mol. Immunol. 2007, v. 44 (12), p. 3243-3255.
  25. Barnett D., Bonham B., Howden M.E. Allergenic cross-reactions among legume foods-an in vitro study. J. Allergy Clin. Immunol. 1987, v. 79, p. 433-438.
  26. Mittag D., Batori V., Neudecker P. et al. A novel approach for investigation of specific and cross-reactive IgE epitopes on Bet v 1 and homologous food allergens in individual patients. Mol. Immunol. 2006, v. 43 (3), p. 268-278.
  27. Todd D.G., Virginia S.L., Pamela H.S., Edwin H.K. Clinical Characteristics of Peanut-Allergic Children: Recent Changes. Pediatric. 2007, v. 120 (6), p. 304-1310.
  28. Al-Muhsen S., Clarke A.E., Kagan R.S. Peanut allergy: an overview. CMAJ. 2003, v. 168 (10), p. 1279-1285.
  29. Vadas P., Wai Y., Burks W., Perelman B. Detection of peanut allergens in breast milk of lactating women. JAMA. 2001, v. 285 (13), p. 1746-1748.
  30. Lack G., Fox D., Northstone K., Golding J. Factors associated with the development of peanut allergy in childhood. N. Engl. J. Med. 2003, v. 348, p. 977-985.
  31. NIAID-Sponsored Expert Panel, Boyce J.A. Assa’ad A. et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J. Allergy Clin. Immunol. 2010, v. 126 (6), p. 1-58.
  32. Lopez-Exposito I., Song Y., Jarvinen K.M. et al. Maternal peanut exposure during pregnancy and lactation reduces peanut allergy risk in offspring. J. Allergy Clin. Immunol. 2009, v. 124 (5), p. 1039-1046.
  33. Sicherer S.H., Sampson H.A. Peanut allergy: Emerging concepts and approaches for an apparent epidemic. J. Allergy Clin. Immunol. 2007, v. 120 (3), p. 491-503.
  34. Hourihane J.B., Kilburn S.A., Nordlee J.A. et al. An evaluation of the sensitivity of subjects with peanut allergy to very low doses of peanut protein: a randomized, double-blind, placebo-controlled food challenge study. J. Allergy Clin. Immunol. 1997, v. 100 (5), p. 596-600.
  35. Maloney J.M., Chapman M.D., Sicherer S.H. Peanut allergen exposure through saliva: assessment and interventions to reduce exposure. J. Allergy Clin. Immunol. 2006, v. 118 (3), p. 719-724.
  36. Vander Leek TK., Liu A.H., Stefanski K. et al. The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. J. Pediatr. 2000, v. 13, p. 749-755.
  37. Romano A., Di Fonso M., Giuffreda F., et al. Food-dependent exercise-induced anaphylaxis: clinical and laboratory findings in 54 subjects. Int. Arch. Allergy Immunol. 2001, v. 125 (3), p. 264-272.
  38. Attou D., Bensekhria S., Dookna P. et al. Asthma caused by peanut in a child. Revue francaise d allergologie. 2004, v. 44 (6), p. 531-534.
  39. Skolnick H.S., Conover-Walker M.K., Koerner C.B. et al. The natural history of peanut allergy. J. Allergy Clin. Immunol. 2001, v. 107 (2), p. 367-374.
  40. Al-Ahmed N., Alsowaidi S., Vadas P. Peanut Allergy: An Overview. All., As. and Clin. Imm. 2008, v. 4 (4), p. 139-143.
  41. Asarnoj A., Moverare R., Ostblom E. et al. IgE to peanut allergen components: relation to peanut symptoms and pollen sensitization. Allergy. 2010, v. 651, p. 189-195.
  42. Asarnoj A., Nilsson C., Lidholm. et al. Peanut component Ara h 8 sensitization and tolerance to peanut. J. Allergy Clin. Immunol. 2012, v. 130 (2), p. 468-472.
  43. Teuber S.S., Beyer K. Peanut, tree nut and seed allergies. C. Opin. A. Clin. Im. 2004, v. 4, p. 201-203.
  44. Roberts G., Lack G. Diagnosing peanut allergy with skin prick and specic IgE testing. J. Allergy Clin. Immunol. 2005, v. 115, p. 1291-1296.
  45. Nicolaou N., Poorafshar M., Murray C., Simpson A. Allergy or tolerance in children sensitized to peanut: Prevalence and differentiation using component-resolved diagnostics. J. Allergy Clin. Immunol. 2010, v. 125 (1), p. 191-197.
  46. Beyer K., Ellman-Grunther L., Jarvinen K.M. et al. Measurement of peptide-specific IgE as an additional tool in identifying patients with clinical reactivity to peanuts. J. Allergy Clin. Immunol. 2003, v. 112 (1), p. 202-207.
  47. Cornelisse-Vermaat J.R., Voordouw J., Yiakoumaki V. et al. Food-allergic consumers’ labelling preferences: a cross-cultural comparison. Eur. J. Public Health. 2008, v. 18 (2), p. 115-120.
  48. Hofmann A.M., Scurlock A.M., Jones S.M. et al. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J. Allergy Clin. Immunol. 2009, v. 124, p. 286-291.
  49. Kim E.H., Bird J.A., Kulis M. et al. Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. Allergy Clin. Immunol. 2011, v. 127 (3), p. 640-646.
  50. Sampson H.A., Leung D., Burks A.W. et al. A phase II, randomized, double-blind, parallel group, placebo-controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy. J. Allergy Clin. Immun. 2007, v. 119, p. 11-17.
  51. Srivastava K.D., Kattan J.D., Zou Z.M. et al. The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J. Allergy Clin. Immunol. 2005, v. 115, p.171-178.
  52. Евдокимова Т.А., Огородова Л.М. Влияние хронической описторхозной инвазии на клиническое течение и иммунный ответ при атопической бронхиальной астме у детей. Педиатрия. 2005, № 6, с. 12-14.
  53. Frick O.L., Teuber S.S., Buchanan B.B. et al. Allergen immunotherapy with heat-killed Listeria monocytogenes alleviates peanut and food-induced anaphylaxis in dogs. Allergy. 2005, v. 60, p. 243-250.
  54. Nowak-Wegrzyn A., Sampson H.A. Future Therapies for Food Allergies. J. Allergy Clin. Immunol. 2011, v. 127 (3), p. 558-573.
  55. Roy K., Mao H.Q., Huang S.K., Leong K.W. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. 1999, v. 5, p. 387-391.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright © Pharmarus Print Media, 2013



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies